NOX — Noxopharm Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Noxopharm, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	R2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	—	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	14	3.01	2.32	1.55	0.294
Net Total Accounts Receivable
Net Total Receivables	5.21	6.08	2.4	2.95	1.51
Prepaid Expenses
Total Other Current Assets
Total Current Assets	20.8	9.16	4.77	4.58	1.83
Net Property, Plant And Equipment	0.222	0.007	0.006	0.004	0.002
Long Term Investments
Other Long Term Assets
Total Assets	26.6	10.1	6.78	4.58	1.84
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	2.28	0.962	1.25	3.87	5.46
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.48	1.06	1.29	3.89	5.48
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	24.1	9.07	5.5	0.69	-3.65
Total Liabilities & Shareholders' Equity	26.6	10.1	6.78	4.58	1.84
Total Common Shares Outstanding